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Abstract 
Background: Although Female Genital Mutilation/Cutting (FGM/C) is internationally considered a harmful practice, 
it is increasingly being medicalized allegedly to reduce its negative health effects, and is thus suggested as a harm 
reduction strategy in response to these perceived health risks. In many countries where FGM/C is traditionally 
practiced, the prevalence rates of medicalization are increasing, and in countries of migration, such as the United 
Kingdom, the United States of America or Sweden, court cases or the repeated issuing of statements in favor of 
presumed minimal forms of FGM/C to replace more invasive forms, has raised the debate between the medical 
harm reduction arguments and the human rights approach. 
Main body: The purpose of this paper is to discuss the arguments associated with the medicalization of FGM/C, a 
trend that could undermine the achievement of Sustainable Development Goal 5.3. The paper uses four country 
case studies, Egypt, Indonesia, Kenya and UK, to discuss the reasons for engaging in medicalized forms of FGM/C, 
or not, and explores the ongoing public discourse in those countries concerning harm reduction versus human 
rights, and the contradiction between medical ethics, national criminal justice systems and international conventions. 
The discussion is structured around four key hotly contested ethical dilemmas. Firstly, that the WHO definition of 
medicalized FGM/C is too narrow allowing medicalized FGM to be justified by many healthcare professionals as a form 
of harm reduction which contradicts the medical oath of do no harm. Secondly, that medicalized FGM/C is a human 
rights abuse with lifelong consequences, no matter who performs it. Thirdly, that health care professionals who 
perform medicalized FGM/C are sustaining cultural norms that they themselves support and are also gaining 
financially. Fourthly, the contradiction between protecting traditional cultural rights in legal constitutions versus 
human rights legislation, which criminalizes FGM/C. 
Conclusion: More research needs to be done in order to understand the complexities that are facilitating the 
medicalization of FGM/C as well as how policy strategies can be strengthened to have a greater de-medicalization 
impact. Tackling medicalization of FGM/C will accelerate the achievement of the Sustainable Development Goal of 
ending FGM by 2030. 
Keywords: Medicalized FGM/C, Harm reduction, Human rights, Medical ethics 
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Plain English summary 
Although Female Genital Mutilation/Cutting (FGM/C) 
is internationally considered a harmful practice, it is 
increasingly being medicalized allegedly to reduce its 
negative health effects, and is thus suggested as a harm 
reduction strategy in response to these perceived health 
risks. 
The purpose of this paper is to discuss the arguments 
associated with the medicalization of FGM/C, a trend 
that could undermine the Sustainable Development Goal 
(5.3) to end FGM/C by 2030. The paper discusses the 
reasons for engaging in medicalized forms of FGM/C, or 
not, by exploring ongoing public discourses in four 
country case studies: Egypt, Indonesia, Kenya and UK. 
The discussion is structured around four key hotly con-
tested ethical dilemmas. Firstly, that the WHO definition 
of medicalized FGM/C is too narrow allowing medical-
ized FGM to be justified by many healthcare profes-
sionals as a form of harm reduction which contradicts 
the medical oath of do no harm. Secondly, that medical-
ized FGM/C is a human rights abuse with lifelong conse-
quences, no matter who performs it. Thirdly, that health 
care professionals who perform medicalized FGM/C are 
sustaining cultural norms that they themselves support 
and are also gaining financially. Fourthly, the contradic-
tion between protecting traditional cultural rights in legal 
constitutions versus human rights legislation, which crimi-
nalizes FGM/C. 
The paper concludes that more research needs to be 
done in order to understand the complexities that are 
facilitating the medicalization of FGM/C as well as how 
policy strategies can be strengthened to accelerate the 
achievement of the Sustainable Development Goal of 
ending FGM by 2030. 
Background 
The trend towards medicalization of FGM/C 
The World Health Organization defines the “medicalization” 
of FGM/C as situations in which FGM/C is practiced by any 
category of health professionals, whether in a public or a pri-
vate clinic, at home or elsewhere, at any point in a female’s 
life (including reinfibulation1) [2]. Health professionals in-
volved in medicalization include physicians, assistant physi-
cians, clinical officers, nurses, midwives, trained traditional 
birth attendants (TBAs), gynecologists/ obstetricians, plastic 
surgeons, and other personnel providing health care to the 
population, in both private and public sectors. They may be 
undergoing medical training, working in the medical sector 
or be retired [2]. 
1Reinfibulation is the procedure to narrow the vaginal opening in a 
woman after she has been deinfibulated (i.e. after childbirth); also 
known as re-suturing [1] 
Medicalization of FGM/C continues to rise in many 
countries despite increasing numbers of countries legis-
lating against the practice. Based on self-reported Demo-
graphic and Health Survey (DHS) data in 25 countries, 
Shell-Duncan and colleagues estimated that 26% of the 
women in the age cohort 15–49, which equals to nearly 
16 million women, report having been cut by a medical 
professional [3]. Medicalization rates, as the percent of 
FGM/C performed by a medical professional, are highest 
in the following five countries: Sudan (67%), Egypt 
(38%), Guinea (15%), Kenya (15%) and Nigeria (13%), 
and rates are rising in all of these countries, except 
Nigeria [3]. The performance of the procedure by skilled 
medical professionals in any setting is systematically 
documented through the inclusion of a question on who 
performs the cutting in the DHS module on FGM/C. 
The increasing use of medical staff and equipment has 
also been noted in Somaliland [4]. Reinfibulation is esti-
mated to affect 20 million women globally and between 
10 and 16 million women are likely to experience medical-
ized reinfibulation. Reinfibulation, medicalized or not, is 
documented in many countries where infibulation is 
(highly) prevalent, e.g. in Sudan, Somalia, Djibouti and 
Eritrea [5] as well as in Europe and North America [6, 7]. 
This paper will use evidence from four countries (Egypt, 
Indonesia, Kenya and UK) to explore current debates 
concerning the medicalization of FGM/C. 
Policies on medicalization of FGM/C 
Initially, campaigns against FGM/C stressed the adverse 
health consequences of the practice, assuming that this 
would help to raise awareness of the health risks and in 
turn motivate people to abandon the practice [8]. How-
ever, it is speculated that the health approach taken in 
these campaigns has unintentionally motivated the 
medicalization of FGM/C, at both demand and supply 
side [2]. In 2009 the World Health Organisation 
(WHO), the United Nations Children’s Fund (UNICEF) 
and the United Nations Populations Fund (UNFPA) 
condemned the medicalization of FGM/C in any setting 
[9], however, WHO had already raised this issue 30 years 
earlier (1979) at an international conference, stating “it 
is unacceptable to suggest that performing less invasive 
forms of FGM/C within medical facilities will reduce 
health complications” [1]. The most recent guidance by 
WHO on the management of health complications from 
FGM/C states: “stopping medicalization of FGM/C is an 
essential component of a holistic, human-rights based 
approach towards the elimination of the practice” [1]. 
In December 2012, the United Nations General As-
sembly adopted the first ever Resolution to ban FGM/C 
worldwide.[10] Resolution A/RES/67/146 was co-
sponsored by two thirds of all UN members and was 
adopted by consensus of all UN members. Its adoption 
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reflected the universal agreement that FGM/C consti-
tutes a violation of human rights, which all countries of 
the world should address through ‘all necessary measures, 
including enacting and enforcing legislations to prohibit 
FGM/C and to protect women and girls.’ More recently, in 
September 2015, the global community agreed a new set of 
development goals, the United Nations Sustainable Devel-
opment Goals (SDGs), which includes Sustainable Develop-
ment Goal 5: achieve gender equality and empower all 
women and girls [11, 12]. This Goal includes a target to 
eliminate all harmful traditional practices, including FGM/ 
C (SDG 5.3), by 2030, a signal of international political will 
to end the practice of FGM/C globally. 
FGM/C whether traditionally performed or medical-
ized, is now recognized internationally as a violation of 
girls’ and women’s rights and as an expression of gen-
dered violence, with a demonstrated impact on women’s 
sexual and reproductive health. Governments worldwide 
are thus obliged to take measures to prevent and elimin-
ate FGM/C, including medicalized forms of the practice, 
and can be held accountable for failing to take steps to 
prohibit the practice of FGM/C through legislative and 
other measures. Some countries have increased the 
prison sentences when health professionals have been 
convicted of performing FGM/C, and some also provide 
for the revocation of licenses of health professionals if 
they perform FGM/C [13]. However, even if the legal 
framework is put in place, a number of challenges re-
main. This paper contributes to four current hotly con-
tested debates on the medicalization of FGM/C, namely: 
i. That the WHO definition of medicalized FGM/C is 
too narrow allowing medicalized FGM to be 
justified by many healthcare professionals as a form 
of harm reduction which contradicts the medical 
oath of do no harm. 
ii. That medicalized FGM/C is a human rights abuse 
with life long consequences, no matter who 
performs it. 
iii. That health care professionals who perform 
medicalized FGM/C are sustaining cultural norms 
that they themselves support and are also gaining 
financially. 
iv. The contradiction between protecting traditional 
cultural rights in legal constitutions versus human 
rights legislation, which criminalizes FGM/C. 
Current debates on medicalization of FGM/C 
When does FGM/C become defined as ‘medicalized FGM/ 
C’ and is medicalized FGM/C an acceptable form of ‘harm 
reduction’? 
Although not specifically addressed in the WHO defin-
ition, we argue that medicalization of FGM/C might also 
include performing less invasive forms of FGM/C, often 
promoted as ‘a harm reduction strategy’. This form of 
medicalization has been documented in African coun-
tries where FGM/C is prevalent, as well as in European 
countries and the USA. Indeed, in 2010 the American 
Academy of Pediatrics issued a position statement in 
which they suggested that ‘it might be more effective if 
federal and state laws enabled pediatricians to reach out 
to families by offering a ritual nick as a possible com-
promise to avoid greater harm”. Such a nick, or prick, 
would consist of pricking the prepuce of the clitoris, 
without removal of tissue. A study in Somaliland, for ex-
ample, showed that there is a trend towards milder 
forms of FGM/C, with “pharaonic circumcision” (Type 
III or infibulation) being replaced by “sunna” cutting 
[14]. Moreover, the study showed that girls are more 
likely to undergo the procedure in a medical facility 
where staff has received at least some medical training. 
A recent study from Nigeria demonstrated that the cam-
paign and legislation against FGM/C and the training of 
nurses concerning the health implications of FGM/C 
made them more cautious and because they knew the 
complications, they were more likely to only nick the 
clitoris enough to cause bleeding and thus satisfy parents 
that the procedure had been done, without removing 
much tissue [15]. 
Another complication with defining medicalized FGM/ 
C is whether the use of medical instruments (such as ster-
ile razor blades or surgical blades, forceps), antibiotics 
and/or anesthetics to carry out FGM/C, especially when 
used by traditional practitioners, should be considered as 
a form of medicalized FGM/C. Data on this are notably 
lacking, and only anecdotal evidence is available. In 
Guinea, the use of razor blades instead of traditional in-
struments is attributed to the increasing medicalization of 
the procedure and sensitization campaigns [16] A qualita-
tive study conducted in four communities in the Nigerian 
States of Delta, Ekiti, Imo and Kaduna, showed that health 
workers used a range of essential supplies when carrying 
out FGM/C: antiseptic, artery forceps, surgical scissors or 
blades, cotton wool, and antibiotics. They described the 
steps of the procedure as: “using an antiseptic to clean the 
area, clamping the tissue with forceps, cutting the tissue 
with scissors or a surgical blade, applying pressure with 
cotton wool to control bleeding, cleaning the area again 
with an antiseptic, and applying an oil or Vaseline”. Some  
‘health workers’ mentioned also administering pain relief 
and prescribing antibiotics [15]. 
Finally, we want to highlight the issue of medicalized 
reinfibulation, and how a recent court case in the UK 
demonstrates the difficulties in defining what constitutes 
medicalized FGM/C, especially in the context of re-
stitching following the birth of a child (reinfibulation). 
The UK case study (see Table 1) is a demonstration of 
an unsuccessful legal case brought against a doctor who 
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Table 1 United Kingdom – when does a medical procedure 
become FGM/C? 
In the United Kingdom (UK), FGM/C has been illegal since 1985 when 
the Prohibition of Female Circumcision Act became law. In 2003 the law 
was amended under the FGM Act (2003) to include an extra-territorial 
clause. In 2015 provisions were strengthened under the Serious Crime 
Act, which extended the scope of extra-territorial offences, granted 
victims of FGM lifelong anonymity; and introduced a new offence of 
failing to protect a girl at risk of FGM (Crown Prosecution Service, nd). 
The law states it is a criminal offence to excise, infibulate or otherwise 
mutilate the whole or any part of a female’s labia majora, labia minora 
or clitoris. However no offence is committed by a registered healthcare 
professional who performs: a surgical operation on a female which is 
necessary for her physical or mental health; or a surgical operation on a 
female who is in any stage of labour, or has just given birth, for 
purposes connected with the labour or birth. It is also an offence to aid, 
abet, counsel or procure FGM [17]. 
After 30 years with no prosecutions under the FGM/C legislation, the 
first prosecution was brought to court in January 2015. It was a high 
profile case involving an alleged medicalized re-infibulation by a doctor 
in a Maternity Unit of a National Health Service (NHS) hospital in 
London. The alleged offence took place in November 2012 when a 24-
year-old woman was brought into the Maternity Unit in labour with her 
first child. It was apparent to the midwife in attendance that she had 
been subjected to type 3 FGM infibulation (which had been performed 
on her at the age of 6 in her home country, Somalia) and that this had 
not been picked up earlier in her pregnancy and was making the birth 
difficult [18, 19]. The doctor was called in and he cut the woman to 
facilitate the safe birth of her child [18]. Following the delivery of the 
child, the doctor, allegedly encouraged by her husband [18], sutured the 
woman, to stop excessive bleeding. However it was claimed by the 
prosecution that the suturing exceeded that which was medically 
required and thus constituted re-infibulation [20]. The case thus revolved 
around whether a figure of eight suture constituted re-infibulation [19]. 
In the period between when the alleged FGM took place and the court 
case, the woman had delivered a second child with no need for surgical 
intervention and she declined to give evidence in court [19, 21]. The 
defendants (the doctor and the woman’s husband) were both acquitted 
of the offence by the jury after only 25 min of deliberation [20, 21]. 
The case has thrown up a number of issues most notably how re-
infibulation is defined, i.e. when does a medical procedure become 
FGM/C. In this prosecution the case consisted of debates and expert 
witness evidence concerning one suture (in a figure of eight, part of 
which involved the stitching of the labia). The prosecution claimed this 
one stitch constituted FGM. This argument was supported by expert 
evidence from health professionals including the midwife involved in 
the delivery room at the time [18]. Other health professionals argued 
otherwise, stating that as the woman had given birth to a second child 
without having to be surgically cut then the suturing could not be 
labeled as reinfibulation. The debate on when a medical procedure 
crosses the legal line to become FGM has not been resolved. However, 
whilst the prosecution did not result in a conviction, it did raise the 
issue of the medicalization of FGM/C in the UK, whether this was 
inadvertent or deliberate. It is not known if any or how many health 
professionals are engaged in medicalized FGM/C in the UK, but this 
highly publicized case provided a stark warning to the medical 
profession that medicalized FGM will not be tolerated in the UK. 
allegedly performed a reinfibulation and illustrates the 
difficulty of proving to a court that FGM/C has taken 
place. However, the huge publicity that occurred during 
and following the court case made it very clear that 
medicalized, as well as traditional FGM/C, was against 
the law and prosecutions would be brought. Since this 
case in 2015, two further unsuccessful cases have been 
brought in the UK against two different fathers of girls 
who have allegedly been subjected to FGM/C. Again, 
these showed a weakness in the law concerning the testi-
mony of the victims and expert evidence from health 
professionals who could not agree whether FGM/C had 
taken place on the girls. However, in February 2019 the 
first successful case was prosecuted in the UK of a 
mother who performed FGM/C using traditional tech-
niques, FGM/C on her three-year-old daughter. 
Medicalized FGM/C: harm reduction or human rights 
abuse? 
One of the most important reasons given by health care 
professionals who perform FGM/C is their belief that 
when it is done by skilled professionals, it reduces the 
immediate health risks and pain, especially when anti-
septic techniques, anesthetic and analgesic medication 
are used [9]. Health professionals doing FGM/C might 
indeed be able to control the immediate physical conse-
quences of cutting the genitals, such as the severe pain, 
bleeding and infections. However, many health profes-
sionals who perform FGM/C have limited knowledge of 
long-term health consequences of the procedure, in par-
ticular the mental health implications. Even if women do 
not report physical after-effects of FGM/C, research sug-
gests that the majority of women subjected to FGM/C 
have reported mental health problems and emotional 
disorders with living with the effects of FGM/C [22]. A 
study by Knipscheer indicated a high level of reporting 
of severe depression, anxiety and Post Traumatic Stress 
Disorder (PTSD) by FGM/C survivors [23]. Eisold found 
that FGM/C can affect the emotional well-being of 
women throughout their lives [24]. 
Whilst medicalized FGM/C might minimize – but not 
avoid - some of the long-term physical consequences of 
FGM/C, the fact remains that there are no perceived 
health benefits of the practice itself. It is therefore con-
sidered to be against good medical practice and a viola-
tion of the medical code of ethics, as even “do less 
harm” is contradictory to the Oath of Hippocrates ‘do 
no harm’. 
Still, the harm reduction approach dominates the dis-
course, as is demonstrated by the high numbers and in-
creasing rates of health professionals that engage in 
performing FGM/C. Health professionals performing 
FGM/C in order to provide a safer setting for the pro-
cedure are ignoring the human rights issues associated 
with FGM/C, including the right to freedom from vio-
lence and discrimination, amongst others. The trend to 
medicalize FGM/C is worrying, given that its impact on 
the global campaign and efforts to end FGM/C is still 
not clear. How the promotion of medicalized ‘safe’ or 
‘light’ versions of cutting girls’ and women’s genitals in-
fluences these efforts is difficult to assess, but it is com-
monly believed that promoting medicalized forms of 
FGM/C communicates the message to practicing 
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communities that FGM/C is acceptable when done by 
health professionals, and thus is a legitimation of the 
practice [1]. This harm-reduction approach contrasts 
with the human rights approach, which states that health 
professionals performing FGM/C in order to provide a 
safer setting for the procedure, are ignoring the human 
rights aspects associated with FGM/C. 
Furthermore, the assumption that medicalization re-
duces harm is not empirically proven. Moreover, in the 
Indonesian case described in Table 2 there is anecdotal 
evidence to the contrary, namely that midwives perform 
more severe forms of FGM/C than traditional practi-
tioners. The case of Indonesia also shows that the 
government has been oscillating between the human 
rights approach and the harm reduction strategy. Govern-
ment policy has played a crucial key role in medicalizing 
FGM/C in Indonesia, together with strong religious/social 
norms that underpinned this medicalization. 
Medicalized FGM/C: reflecting the social norm or used to 
justify financial gain? 
One aspect that plays a key role in health care profes-
sionals deciding to do FGM/C is that they commonly 
share the same social norms regarding cutting the geni-
tals of girls and women, hence resisting the pressure or 
the demand to do FGM/C from the community is chal-
lenging. A study from Nigeria for example, demon-
strated that most health workers that engage in FGM/C 
do so because they share the same FGM/C beliefs as the 
community they serve, and this was evidenced by the 
fact that four out of five health workers with daughters 
had also cut their own daughters [15]. Another study, 
from Sudan, concluded that medicalization is primarily 
driven by the demand motivated by social norms [31]. 
The patriarchal nature of FGM/C underpins many of 
the arguments to continue FGM/C, whether it is medi-
calized or not, and parallels between FGM/C, patriarchy 
and female genital surgeries have been discussed else-
where by various scholars (see for example Pedwell C 
[32], Ogbe E et al. [33]). 
However, the financial gains to perform FGM/C for 
both health professionals and parents should not be 
underestimated, as FGM/C can bring in additional income 
to health professionals and for parents it can mean a 
higher bride price/dowry can be expected when their 
daughter is married. Health professionals’ motivation to 
perform FGM/C is reinforced by the fact that many health 
systems in countries where FGM/C is prevalent are weak, 
and so extra financial income is attractive. Serour suggests 
that medicalization of FGM/C is a major source of income 
for those who perform it. Fees are high, especially in coun-
tries where FGM/C is illegal [9, 34]. 
This is demonstrated by the case study that looks at 
Egypt, where medical doctors have taken the lead in the 
Table 2 Indonesia – is the debate “harm-reduction vs. human 
rights” meaningful? 
Indonesia has one of the highest burdens of FGM/C in the world, with 
51% of the girls 0 to 11 years having been circumcised [25]. In 
Indonesia, it is widely believed that FGM/C is a necessary fulfilment of 
the Islamic religion [26, 27]. The fatwa, a recognised body for the 
preservation of Muslim culture in a secular-led government, argues in 
favour of FGM/C, by defining FGM/C as the removal of the membrane 
that covers the clitoris, through scratching without cutting or incision of 
the clitoris. 
FGM/C in Indonesia was traditionally conducted by traditional birth 
attendants, as well as traditional and religious practitioners. When the 
government rolled out a maternal health programme to reduce 
maternal deaths in the 1990s, it transferred duties of maternity care and 
delivery to midwives. Since then clinics and hospitals have increasingly 
offered FGM/C as part of the delivery package with midwives being the 
frequently cited personnel performing FGM/C [28]. The proportion of 
FGM/C performed by midwives and other medical professionals has 
sharply increased from 32 to 52% between 2003 and 2013 [25, 29]. 
Countrywide, two-thirds (65%) and two-fifths (40%) of the FGM/C in 
urban and rural areas respectively, are now being performed by mid-
wives and other health personnel [25]. 
The last decade has seen the heightening of the debate on FGM/C in 
Indonesia leading to periods of banning and unbanning of FGM/C. 
Activists call for its banning while the fatwa religious fathers lobby for 
its continuation. In the 1990s and early 2000s the government was silent 
on the WHO’s global call to eliminate FGM/C [30]. In the absence of 
government policy and intervention, midwives responded to women’s 
demands for FGM/C by conducting FGM/C in health facilities to those 
who requested it [28]. Following the call for the respect for women and 
girls’ rights surrounding FGM/C, the government banned FGM/C in 
2006. In response, the fatwa lobbied the government to rescind the ban 
arguing that FGM/C was a cultural rite of passage for all Islamic women 
and must be provided upon parental request on behalf of their children, 
but that it must be done without causing psychological or physical 
danger to the woman or girl. Instead of maintaining its stance on the 
ban, the government gave in and spelt out conditions under which 
FGM/C could be done. A standard operating procedure allowing only 
medical personnel to conduct FGM/C in a safe and hygienic manner 
and to children of parents who requested it was then put in place. 
In 2014 women’s organizations successfully contested the policy 
arguing that FGM/C has no medical benefits for women and girls as 
opposed to male circumcision. Despite the ban that prohibits FGM/C 
being in place, no sanctions are given for those who transgress this law. 
Women’s organizations recommended that the government should 
address the problem, including providing rehabilitation to women living 
with FGM/C, criminalise the practice and campaign against the practice 
[25]. 
Medicalized FGM/C is argued to be a better of the two evils 
(medicalized versus traditional FGM/C) in that it is done by trained and 
skilled health professionals in hygienic and medically controlled 
situations compared to the traditional birth attendants who conduct it 
in uncontrolled settings with severe pain and complications [26]. 
However, the opposite has been reported as midwives in Indonesia, 
were found to perform more invasive and painful forms of excision in 
68–88% observed cases compared to 43–67% cases by traditional 
providers [29]. There is also some concern that as FGM/C has become 
more medicalised, more physically invasive forms of FGM/C are now 
more common. However, there is also some evidence that midwives 
who disagree with FGM/C are performing type 1 or type 4, to satisfy 
parents that FGM/C has taken place but at the same time minimizing 
the risk to girls, thus demonstrating that the human rights arguments 
might gain some impact on the medicalization of FGM/C in Indonesia. 
In a few instances midwives are said to provide “psychological FGM/C” 
and not real FGM/C. Hidayana et al. argue that since parents do not 
know how the midwives conduct FGM/C, some midwives who do not 
support it pretend to be doing FGM/C to fulfil the client’s request [28]. 
This case also demonstrates that medical professionals are impacted on 
by the same social norms as parents and stresses the role medical 
professionals play in ending FGM/C, which is further discussed in the 
following section. 
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medicalization of FGM/C, often arguing that as FGM/C 
is a strong social norm and will happen whatever, that it 
is better that it is performed by a medical doctor than a 
traditional practitioner (Table 3). It has also been argued 
that many of these doctors support the practice for cul-
tural and religious reasons and in addition make a good 
livelihood from performing the procedure. Despite cases 
where girls have died following medicalized FGM/C, few 
successful prosecutions have taken place against a med-
ical professional in Egypt [42]; a country where medical-
ized FGM/C is highly prevalent and numbers rising. The 
Egyptian case study shows us the importance of the con-
text in which FGM/C arises. 
FGM/C: cultural rights versus human rights? 
Both the Egyptian case discussed above and the Kenyan 
case discussed hereafter (Table 4) demonstrate how 
the law has limited influence in contradiction with cul-
ture and tradition. It shows how FGM/C is embedded in 
cultural and traditional norms and rights that are con-
sidered by proponents to prevail over the law of the 
country. 
As alluded to in the Kenyan case of a medical doctor 
supporting the medicalization of FGM/C, there may be 
Table 3 Egypt – the contradiction between social norms and 
legal frameworks 
Worldwide more than half of all medicalized FGM/C procedures are 
performed in Egypt [3] and medicalization rates in Egypt are rising. 
Available data show that the percentage of girls cut by health 
professionals increased from 55% in 1995 to 77% in 2008 [35] and 84% 
in 2014 (EDHS, 2014). 
In Egypt, policies and laws related to the medicalization of FGM/C have 
undergone a number of shifts. In 1994, in an attempt to improve the 
safety of FGM/C, the government gave its consent for FGM/C when 
performed by health personnel in public hospitals [35]. This government 
consent aimed at improving the safety of FGM/C, in a context where 
people viewed the practice as inevitable. The Egyptian Minister of 
Health at the time stated that the medicalization of FGM/C would 
reduce complications and eventually end the practice [9, 36]. Women’s 
rights and health advocates criticized the consent as government 
endorsement of FGM/C. In 1995, after the death of a girl in a hospital 
during a FGM/C procedure [38], this policy was revised. First 
governmental hospitals, and later private hospitals were banned from 
performing the procedure, except ‘when medically necessary’. The 
prerequisite of medical necessity functioned as a loophole until 2006 
[35, 36, 38]. In 2007 further restrictions banned all state-licensed health 
workers in either government or private clinics from performing FGM/C. 
In 2008 performing FGM/C was criminalized in the penal code [35]. 
Initially FGM/C was covered as a misdemeanor, imposing the penalty of 
imprisonment between 3 months and 2 years on practitioners of FGM/ 
C. In 2016, following several deaths of girls while undergoing FGM/C, 
the law was strengthened and enforced with increased sentences. In 
2016 the penalty of imprisonment was raised from five to 7 years for 
medical practitioners. If the practice led to death or permanent disability 
the imprisonment could be up to 15 years. Moreover, a penalty of 
imprisonment between one and 3 years was imposed for any individual 
who escorted the victims of such crimes to the perpetrators [39]. 
However, a number of recent studies reveal that despite these 
policies and legal restrictions the medicalization of FGM/C continues 
in Egypt [35, 40, 41]. 
Table 4 Kenya – the intersectionality between tradition, culture 
and human rights 
Kenya witnessed a gradual decline in prevalence of FGM/C from 38% in 
1998 to 21% in 2014 (KDHS 2014). However, over the same time the 
rates of medicalization have been on the rise, increasing from 34% in 
1998 to 41% in 2008–09, followed by a subsequent drop in 2014 [3]. 
More worrying are the rates of medicalization of FGM/C of girls as 
facilitated by their parents in Kenya which is reported to be 20% [40]. 
Kenya has taken steps towards criminalizing FGM/C, which is evidenced 
by the various policies and laws passed in the recent past such as the 
Prohibition of Female Genital Mutilation Act 2011 and the Child Act 
policy. However, there are a number of challenges that Kenya has faced 
with regard to the implementation of these laws and policies. For 
example, on 13th June 2014, after some perpetrators of FGM/C were 
arrested [43], more than 500 agitated women from the Maasai 
community held a protest at a shopping center in Kajiado Central, 
advocating for FGM/C and calling for the government to allow them to 
practice FGM/C. The women demonstrated against the enforcement of 
the law in their county after the arrest of the parents of a 13 year-old 
girl who died in a botched traditional FGM/C procedure. The protesters 
cited the Kenyan Constitution, which provides for the protection of 
cultural and traditional rights and subsequently their right to practice 
FGM/C viewed as an age-old custom that is believed to be necessary 
for womanhood. Such cases begin to raise concerns about the need to 
sensitize and create awareness among members of communities that 
practice FGM/C about harmful practices and how they infringe on girls 
and women’s rights to bodily and mental integrity. Communities need 
to de- and re-construct social norms in order to make progress in 
achieving the SDGs. 
One of the latest challenges that has captured both local and 
international attention is the recent court case, filed by a Kenyan, female 
medical doctor petitioning the High Court to overturn the law that 
outlaws FGM/C in Kenya. The medical doctor argued against the term 
‘mutilation’ which she viewed as a ‘misnomer’, and reiterated “female 
circumcision was part and parcel of African cultural practices before 
colonialism, and as such should not be made illegal”. She added, “[ …] 
once you reach adulthood there is no reason why you should not make 
that decision”. She argued that “legalizing female circumcision will make 
it easy for those who want to undergo it to seek the best medical 
services, thus making the procedure safe” [44]. In her discussion, she 
also justified the medicalization of the practice by saying that “female 
circumcision [ …] can be made safe arguing that it is a minor surgical 
procedure that does not require anesthesia or being put into a theater” 
[44]. It demonstrates that FGM/C is a practice based on cultural beliefs 
and deeply embedded social norms; even well educated health care 
providers find it hard to not comply with the prevailing social norms. 
gaps in the law that proponents of FGM/C might use to 
push their agenda. This case indicates that some medical 
practitioners themselves do not only medicalize, or 
support it, but do so by exploiting gaps in the judicial 
system hence derailing progress made towards aban-
donment of FGM/C. 
Discussion 
Tackling the medicalization of FGM/C needs to consider 
the contested issues surrounding the debate of medical-
ized FGM/C. In the current paper we discussed four im-
portant issues and dilemmas that should be taken into 
account: the trouble with defining FGM/C, the need to 
contextualize FGM/C, the debate of harm-reduction ver-
sus social norm and the difficulty of applying a law when 
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it contradicts cultural values and social norms. In con-
clusion to this paper we want to translate the discussions 
above to some suggestions for the way forward. 
Policy emphasizing the human rights approach 
As demonstrated there is a tension between a pragmatic 
harm reduction approach maintained by some health pro-
fessionals and the human rights approach that seeks to 
safeguard girls and women’s bodily integrity. Social and 
religious norms supporting the practice of FGM/C pose 
serious challenges to the implementation of legislation 
that aims to protect the human rights of women and girls. 
In both Egypt and Indonesia the governments have at vari-
ous times supported the medicalization of FGM/C as a harm 
reduction strategy, often under great pressure from religious 
leaders, resulting in a confused response to FGM/C and its 
medicalization which undermined efforts to end the prac-
tice in line with international agreements. In Kenya, Egypt 
and Indonesia, FGM/C practicing communities and the 
health profession have been very vocal and at times mili-
tant in advocating against national legislation banning 
FGM/C. Very often these groups have used constitutional 
arguments such as the preservation of cultural and trad-
itional rights, to support their case. These three case stud-
ies reveal that at various times over the last 20 years the 
harm reduction approach to FGM/C has taken policy pre-
cedence over the human rights approach to FGM/C. 
FGM/C is a strong social norm that makes it difficult 
for individuals to challenge, as the practice often occurs 
in societies where norms of collectivity are predominant. 
The impact of these different settings on social norm 
change and human rights is not in the scope of this 
paper and has been discussed elsewhere by various au-
thors (see for example Diabate et al. [45], UNICEF [46], 
Leye et al. [47]). 
There is now a growing momentum in many high 
FGM/C prevalence countries and others, to tackle FGM/ 
C from a human rights perspective, 25 years after the 
World Conference on Human Rights held in Vienna, 
Austria in 1993 accepted that FGM/C was a violation of 
human rights. In 2008 the United Nations Special 
Report on Torture stated that violence against women, 
including FGM/C can be considered a violation of the 
Convention Against Torture.[51] Regionally several 
treaties and consensus documents call for the protection 
of the rights of women and girls through the abandon-
ment of FGM/C. These include the African Charter on 
Human and People’s Rights (The Banjul Charter) and the 
Protocol on the Rights of Women in Africa (Maputo 
Protocol), the African Charter on the Rights and Wel-
fare of the Child, and the European Convention for the 
Protection of Human Rights and Fundamental Free-
doms [30]. More recently, in September 2017 at a 
meeting in Egypt jointly organized by UNFPA and the 
League of Arab States, public statements were made by 
National Doctors’ Syndicates and Medical Councils as 
well as the National Midwives Associations in the Arab 
Region to end the medicalization of FGM/C. 
Educating health professionals on FGM/C and its 
consequences 
Awareness raising on the sexual and reproductive health 
consequences of FGM/C and the human rights viola-
tions, as well as building capacities through inclusion of 
FGM/C in curricula or postgraduate training of profes-
sionals likely to deal with FGM/C are some of the most 
commonly used strategies to involve health professionals 
in countering medicalization. From the case studies dis-
cussed above the importance of having a clear definition 
of medicalized FGM/C, such that it’s clear to health pro-
fessionals when they are performing FGM/C, and thus 
breaking the law, is highlighted. Moreover, they should 
be aware of the negative psychological and physical con-
sequences of performing FGM/C. 
Training of health care professionals on FGM/C can 
vary across and between countries and can take different 
forms, such as the provision of specific training work-
shops on medicalization or general training on FGM/C, 
the inclusion of FGM/C in medical curricula, or the 
development of e-learning modules or other tools on 
FGM/C. It should be noted however, that very few of 
these training and capacity building efforts, especially re-
garding medicalization, are evaluated, hence it remains 
unclear what the most effective methods of awareness 
raising amongst health professionals might be. More-
over, a recent analysis of the evidence on knowledge, ex-
periences and attitudes of health professionals towards 
FGM/C showed that there are six areas for improvement 
for health care providers. These areas are: knowledge of 
FGM/C and its consequences, adherence to FGM/C pro-
tocols and guidelines, socially constructed acceptance of 
FGM/C, knowledge of legislation and legal status of 
FGM/C, condoning, sanctioning or supporting FGM/C 
and information and training to work with women and 
girls living with FGM/C [48]. This list indicates that 
much work still needs to be done. 
It is commonly assumed that the reproductive and 
sexual health consequences, the legal repercussions as 
well as the human rights dimension should be part of 
any FGM/C module in the curricula of health profes-
sionals. The WHO Guidelines (2016) on the manage-
ment of health complications from FGM/C, are useful 
for designing pre- and in-service professional training 
curricula for health care providers, and include the 
above-mentioned aspects. However, too often, FGM/C is 
not included in curricula on a systematic basis, and/or 
medicalization and the preventive role of health profes-
sional is not addressed at all. Moreover, capacity-
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building on how to resist pressures from the community, 
as well as communication techniques for social norm 
change are rare. A study from Nigeria showed that 
health workers should be educated and empowered to 
advocate for the abandonment among patients but also 
among fellow health workers [15]. Studies from The 
Gambia showed that training programmes should be 
modeled to fit the specific characteristics of the trainees 
in terms of sex and ethnicity [49]. 
Detangling professional norms from social norms 
The above demonstrates that any effort to deal with 
medicalized FGM/C should take into account the con-
text in which it occurs. Health care providers’ under-
standing about FGM/C and how their opinions are 
shaped by social norms should be unpacked. Many 
health professionals are not aware of the long-term 
health implications of FGM/C and the fact that it is a 
violation of human rights and a breach of medical ethics, 
despite many regional and global protocols cited above 
condemning it. Moreover, health professionals often 
share the social norms of FGM/C being an important 
cultural tradition. Additionally, the financial reward for 
performing FGM/C is attractive to health professionals, 
especially in a weak health system. 
We are therefore advocating that health professionals 
receive training to raise their knowledge of the issues 
surrounding FGM/C and the awareness that performing 
FGM/C is in contradiction with the Oath of Hippocrates 
‘you should do not harm’. In particular, medicalization 
of FGM/C and how to tackle it should be part of any 
curriculum of health professionals (pre and postgraduate 
training). The legal interpretations of what constitutes a 
crime with regards to medicalization of FGM/C need to 
be made clear among health professionals. 
Codes of conduct or position statements by profes-
sional organizations have been issued both in Western 
countries as well as in countries where FGM/C is most 
prevalent. Some of these position statements have 
caused controversy, such as the 2010 Statement by the 
American Association of Pediatrics that promoted the 
performance of a ‘ritual nick’. This statement was revised 
after outrage and fierce opposition by WHO and others. 
The European Academy of Pediatricians on the other 
hand, clearly states: “It also calls upon all physicians to 
help to stop this practice. The practice of offering a “clit-
oral nick”, a minimal pinprick, must also be condemned 
as an unnecessary and extremely painful procedure [50]”. 
Motivate health care providers as agents of change for 
ending FGM/C 
Even though health professionals are at the core of the 
medicalization issue, they can and are targeted as part of 
the solution to reverse the medicalization of FGM/C. 
Given that they are important role models in societies, 
they are often key in becoming agents of change regard-
ing FGM/C. However, a scoping survey would need to 
be conducted in each country where medicalized FGM/ 
C is performed to assess the knowledge, attitudes and 
practices of health professionals in the practicing of 
medicalized FGM/C. 
From our discussion above, it is clear that more atten-
tion should go to how health care professionals can be 
used as agents of change for ending FGM/C. This can 
be done through: 
– Including, more systematically, the human rights 
framework and the ethics of medicalization of FGM/ 
C in curricula of health professionals’ education and 
training. 
– Building bridges between sectors: linkages between 
health professionals and legal stakeholders should 
be explored and reinforced in order to make the 
implementation of laws banning FGM/C more 
effective. 
– Establishing collaborations between health 
professionals and religious leaders to agree that 
FGM/C is not a religious requirement and to 
communicate this to FGM/C practicing 
communities. 
– Developing strategies on how health professionals 
can deal with social pressures  from  the  
community wanting to continue with FGM/C and 
to challenge the social norms perpetuating the 
practice. 
– Urging Professional Medical Associations to 
reinforce the unethical nature of the medicalization 
of FGM/C and produce public statements and 
protocols advocating for the ending of FGM/C 
whether performed in traditional or medicalized 
settings, including reinfibulation. 
Conclusion 
This paper has discussed the complex ethical debates 
that accompany the medicalization of FGM/C, and the 
contradictions between the social and cultural norms 
supporting the continuation of FGM/C and the human 
rights of women and girls. It is clear that more attention 
should go to how health care professionals can be used 
as agents of change for ending FGM/C. It is also clear 
that more research needs to be done in order to de-
cipher the code that will facilitate the detangling of these 
social norms from health professional norms and human 
rights. It is essential that we have a deeper understand-
ing of the issue and the process of medicalization of 
FGM/C if the United Nations SDG 5.3 of ending FGM 
by 2030 is to be achieved. 
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